GlobeNewswire
Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement
📊
AI Sentiment
Positive
6/10
- Home
- LXRX
as of 02-12-2026 4:00pm EST
$1.31
$0.06
-4.38%
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
| Founded: | 1995 | Country: | United States |
| Employees: | N/A | City: | THE WOODLANDS |
| Market Cap: | 465.2M | IPO Year: | 2000 |
| Target Price: | $3.23 | AVG Volume (30 days): | 4.1M |
| Analyst Decision: | Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.19 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.28 - $1.83 | Next Earning Date: | 03-05-2026 |
| Revenue: | $70,864,000 | Revenue Growth: | 1255.21% |
| Revenue Growth (this year): | 56.61% | Revenue Growth (next year): | -56.07% |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | -72583000.0 | FCF Growth: | N/A |
AI-Powered LXRX Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 72.22%
72.22%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Lexicon Pharmaceuticals Inc. (LXRX)
Invus Global Management, LLC
Buy
Director, 10% Owner
LXRX Feb 2, 2026
Avg Cost/Share
$1.30
Shares
1,538,462
Total Value
$2,000,000.60
Owned After
1,538,462
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Invus Global Management, LLC | LXRX | Director, 10% Owner | Feb 2, 2026 | Buy | $1.30 | 1,538,462 | $2,000,000.60 | 1,538,462 |
Latest Lexicon Pharmaceuticals Inc. News
LXRX Breaking Stock News: Dive into LXRX Ticker-Specific Updates for Smart Investing
Compare LXRX vs Leading Stocks
See how LXRX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "LXRX Lexicon Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.